Login / Signup

Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial.

Rolf-Markus SzeimiesChristoph AbelsAna KilicHubert ReichBirgit BergerErik Schulze Zur WiescheKatharina SchrammLeonie LitzkaSusanne Heimstaedt-MuskettClarissa Masur
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Treatment with 1% GPB cream over 72 weeks significantly reduces sweat production and improves quality of life in patients with severe PAHH. One percent GPB cream is well-tolerated and provides an effective treatment option for long-term use in patients with severe PAHH.
Keyphrases
  • early onset
  • lymph node
  • clinical trial
  • randomized controlled trial
  • squamous cell carcinoma
  • study protocol
  • drug induced
  • early stage
  • phase iii
  • ultrasound guided
  • gestational age